Shinjo Ophthalmologic Institute
Miyazaki, 880-0035, Japan
NCT Number: NCT00927628
The purpose of this investigation was to determine the incidence and the factors that cause a reopening of a macular hole (MH) after a surgical closure.
Looking for future studies?
Notify Me40 year–80 year
All sexes
Observational
Miyazaki, 880-0035, Japan
A reopening of a macular hole (MH) is a well-known complication of successfully closed MHs. Recently, internal limiting membrane (ILM) peeling has become widely used as an adjunctive procedure during MH surgery. The incidence of a reopening of a MH is 0 to 8.6% in eyes in which the ILM was peeled off, and 2 to 16% in which the ILM was not peeled off. Part of the variation in the percentages of reopening was the length of the follow-up period; eyes with longer follow-up periods have higher incidences of reopening.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients underwent vitrectomy with or without internal limiting membrane (ILM) peeling for an idiopathic full-thickness macular holes. Simultaneous phacoemulsification with intraocular lens implantation was performed on all phakic patients who were >40-years-of-age.
Time frame: Patients were examined preoperatively and postoperatively on day one, and at two weeks, and one, three, and six months. Thereafter, they were examined every three to six months.
Shinjo Ophthalmologic Institute
Other
Incidence and Factors Related to Macular Hole Reopening
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06915948
Eye Diseases, Macular Holes
Palakkad, Kerala, India
View Trial DetailsNCT05710458
Epiretinal Membrane, Eye Diseases
Hong Kong
View Trial DetailsNCT03701542
Eye Diseases, M-charts
View Trial DetailsNCT07495319
Eye Diseases, Retina Disorder
Karachi, Pakistan
View Trial Details